newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026

  • Eton Pharmaceuticals, Inc. will report third quarter 2026 financial results on Thursday, November 5, 2026.
  • Management will host a conference call & live audio webcast at 4:30 p.m. ET to discuss the results.
  • Investors may submit emailed questions to investorrelations@etonpharma.com in addition to live call questions.
  • The webcast & archived recording will be available on the Investors section of Eton's website at ir.etonpharma.com.
  • Eton currently markets twelve rare disease products including KHINDIVI, INCRELEX, ALKINDI SPRINKLE, & HEMANGEOL.
  • The company has five late-stage product candidates: ASN-001, AMGLIDIA, ET-700, ET-800, & ZENEO hydrocortisone autoinjector.
  • In-Site Communications, Inc. serves as the investor relations contact for Lisa M. Wilson.